Home
>
National Drug Code (NDC)
>
Treatment Set TS349632
Treatment Set TS349632 - 49288-0920-3 - (Treatment Set TS349632)
Drug Information of Treatment Set TS349632
| Product NDC: | 49288-0920 |
| Proprietary Name: | Treatment Set TS349632 |
| Non Proprietary Name: | Treatment Set TS349632 |
| Active Ingredient(s): | .00008; 80; 160; .0004; 160; .00008 g/mL; [BAU]/mL; [BAU]/mL; g/mL; [BAU]/mL; g/mL & nbsp; Treatment Set TS349632 |
| Administration Route(s): | INTRADERMAL; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Treatment Set TS349632
| Product NDC: | 49288-0920 |
| Labeler Name: | Antigen Laboratories, Inc. |
| Product Type: | NON-STANDARDIZED ALLERGENIC |
| FDA Application Number: | BLA102223 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19861031 |
Package Information of Treatment Set TS349632
| Package NDC: | 49288-0920-3 |
| Package Description: | 10 mL in 1 VIAL, MULTI-DOSE (49288-0920-3) |
NDC Information of Treatment Set TS349632
| NDC Code | 49288-0920-3 |
| Proprietary Name | Treatment Set TS349632 |
| Package Description | 10 mL in 1 VIAL, MULTI-DOSE (49288-0920-3) |
| Product NDC | 49288-0920 |
| Product Type Name | NON-STANDARDIZED ALLERGENIC |
| Non Proprietary Name | Treatment Set TS349632 |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRADERMAL; SUBCUTANEOUS |
| Start Marketing Date | 19861031 |
| Marketing Category Name | BLA |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | AVENA SATIVA POLLEN; CYNODON DACTYLON POLLEN; FESTUCA PRATENSIS POLLEN; PASCOPYRUM SMITHII POLLEN; PHLEUM PRATENSE POLLEN; SORGHUM HALEPENSE POLLEN |
| Strength Number | .00008; 80; 160; .0004; 160; .00008 |
| Strength Unit | g/mL; [BAU]/mL; [BAU]/mL; g/mL; [BAU]/mL; g/mL |
| Pharmaceutical Classes | Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
